# Howard Colman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/howard-colman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,200 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 71 |
| i10-index | 147 |
| Last Known Institution | University of Utah |
| OpenAlex ID | https://openalex.org/A5047608444 |
| ORCID iD | 0000-0002-4027-7317 |
| Works | 407 |

## Researcher papers

- [Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis](https://scholariq.org/papers/molecular-subclasses-of-high-grade-glioma-predict-prognosis-delineate-a-pattern/)
- [A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma](https://scholariq.org/papers/a-randomized-trial-of-bevacizumab-for-newly-diagnosed-glioblastoma/)
- [Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma](https://scholariq.org/papers/molecular-profiling-reveals-biologically-discrete-subsets-and-pathways-of/)
- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [The transcriptional network for mesenchymal transformation of brain tumours](https://scholariq.org/papers/the-transcriptional-network-for-mesenchymal-transformation-of-brain-tumours/)
- [A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma](https://scholariq.org/papers/a-first-in-human-phase-0-clinical-study-of-rna-interference-based-spherical/)
- [Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma](https://scholariq.org/papers/randomized-phase-ii-and-biomarker-study-of-pembrolizumab-plus-bevacizumab-versus/)
- [Caregiver burden by treatment and clinical characteristics of patients with glioblastoma](https://scholariq.org/papers/caregiver-burden-by-treatment-and-clinical-characteristics-of-patients-with/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [University of Utah](https://scholariq.org/institutions/university-of-utah/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.